[1] Salomon B, Bluestone JA. Complexities of CD28/B7:CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol, 2001, 19: 225-252. [2] Bijl M, Horst G, Limburg PC, et al. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis, 2001, 60: 523-526. [3] Nagafuchi H, Shimoyama Y, Kashiwakura J, et al. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. Clin Exp Rheumatol, 2003, 21: 71-77. [4] 沈斌,许冰,李敏伟.系统性红斑狼疮患者外周血淋巴细胞CD80和CD86的表达.中华皮肤科杂志,2003,36:13-15. [5] Schweitzer AN, Sharpe AH. Studies using antigen-presenting cells lacking expression of both BT-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J Immunol, 1998,161: 2762-2771. [6] Funauchi M, Yoo BS, Nozaki Y, et al. Dysregulation of the granulocyte-macrophage colony-stimulating factor receptor is one of the causes of defective expression of CD80 antigen in systemic lupus erythematosus. Lupus, 2002, 11: 317-321. [7] Denfeld RW, Kind P, Sontheimer RD, et al. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum, 1997, 40: 814-821. [8] Lee KM, Chuang E, Griffin M, et al. Molecular basis of T cell inactivation by CTLA-4. Science, 1998, 282: 2263-2266. |